TPIDB > Principal Investigator
Principal Investigator
Linkou Chang Gung Medical Foundation
(在職)
Division of Dermatology
Division of Others-Immunodermatology, Adverse drug reactions, Drug hypersensitivity, Pharmacogenomics
Division of General Internal Medicine
Taipei Chang Gung Medical Foundation
(在職)
Division of Dermatology
Division of Others-Immunodermatology, Adverse drug reactions, Drug hypersensitivity, Pharmacogenomicspsoriasis,
Chang Gung Medical Foundation Chang Gung Memorial Hospital, Keelung
Division of Dermatology
更新時間：2023-10-24
鐘文宏Chung, Wen-Hung
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
-
chung1@cgmh.org.tw
Publication
82Publications
51
32. Chung WH, Pan RY, Chu MT, Chin SW, Huang YL, Wang WC, Chang JY, Hung SI*. Oxypurinol- Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions. J Invest Dermatol. 2015 May Sep;135(9):2237-2248. (SCI; IF=6.344; Immunology: 20/151; Infectious diseases: 5/83; Microbiology: 14/123)
52
31. Yang CY, Chen CH, Deng ST, Huang CS, Lin YJ, Chen YJ, Wu CY, Hung SI, Chung WH*. Allopurinol Use and Risk of Fatal Hypersensitivity Reactions: A Nationwide Population-Based Study in Taiwan. JAMA Intern Med. 2015 Sep 1;175(9):1550-7. (SCI; IF=14; Medicine, General & Internal 6/155)
53
30. White KD, Chung WH, Hung SI, Mallal S, Phillips EJ. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. J Allergy Clin Immunol. 2015 Aug;136(2):219-34. (SCI; IF=12.485; Allergy: 1/25; Immunology: 5/151)
54
29. Wu J, Lee YY, Su SC, Wu TS, Kao KC, Huang CC, Chang WC, Yang CH, Chung WH*. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies. Br J Dermatol. 2015 Nov;173(5):1224-31. (SCI; IF=4.317; Dermatology: 5/61)
55
28. Dodiuk-Gad RP, Chung WH, Valeyrie-Allanore L, Shear NH. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update. Am J Clin Dermatol. 2015 Dec;16(6):475-93. (SCI; IF=3.084; Dermatology: 9/61)
56
27. Chung WH, Chu CY, Huang YH, Wang WM, Yang CH, Tsai TF. Taiwanese Dermatological Association consensus for the definition, classification, diagnosis, and management of urticaria. J Formos Med Assoc. 2015 Dec 8. pii: S0929-6646(15)00338-1. doi: 10.1016/j.jfma.2015.09.009. [Epub ahead of print]. (SCI; IF=2.018; Medicine, General & Internal 46/155)
57
26. Chang CC, Ng CC, Too CL, Choon SE, Lee CK, Chung WH, Hussein SH, Lim KS, Murad S. Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population. Pharmacogenomics J. 2016 Mar 1. doi: 10.1038/tpj.2016.10. [Epub ahead of print]. (SCI; IF=3.784; Genetics & heredity: 47/166; Pharmacology & pharmacy: 52/255)
58
25. Dodiuk-Gad RP, Olteanu C, Chung WH, Shear NH. The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015. Drug Saf. 2016 Mar;39(3):271-6. (SCI; IF=3.206; Public, environmental & occupational health: 29/173; Pharmacology & pharmacy: 68/255; Toxicology: 21/90)
59
24. Day R, Hung SI, Chung WH. Allopurinol dose relative to renal function and risk of hypersensitivity reactions. Ann Rheum Dis. 2016 Apr;75(4):e21. (SCI; IF=12.384; Rheumatology: 1/32)
60
23. Ng CY, Yeh YT, Wang CW, Hung SI, Yang CH, Chang YC, Chang WC, Lin YJ, Chang CJ, Su SC, Fan WL, Chen DY, Wu YJ, Tian YC, Hui RC, Chung WH*; Taiwan Severe Cutaneous Adverse Reaction Consortium. Impact of the HLA-B*58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions. J Invest Dermatol. 2016 Jul; 136(7): 1373-81. (SCI; IF=6.915; Dermatology: 1/61)
